Ribomic Inc. (TYO:4591)
Japan · Delayed Price · Currency is JPY 88.00
+4.00 (4.76%)
Aug 27, 2026, 3:30 PM JST
Ribomic Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7.5 | 3 | 2 | - | 65 | 80 | |
Revenue Growth | 650.00% | 50.00% | - | - | -18.75% | -12.09% |
Cost of Revenue | - | 1 | - | - | - | - |
Gross Profit | 7.5 | 2 | 2 | - | 65 | 80 |
Selling, General & Admin | 410.11 | 353 | 385 | 352 | 361 | 313 |
Research & Development | 838.58 | 803 | 667 | 764 | 1,491 | 1,482 |
Other Operating Expenses | - | 53 | - | - | - | 34 |
Operating Expenses | 1,249 | 1,209 | 1,052 | 1,116 | 1,852 | 1,829 |
Operating Income | -1,241 | -1,207 | -1,050 | -1,116 | -1,787 | -1,749 |
Interest & Investment Income | 14.7 | 12 | 4 | 1 | 2 | - |
Currency Exchange Gain (Loss) | 0.28 | - | - | 10 | 20 | 11 |
Other Non Operating Income (Expenses) | 44.02 | 56 | 31 | 122 | 116 | 103 |
EBT Excluding Unusual Items | -1,182 | -1,139 | -1,015 | -983 | -1,649 | -1,635 |
Asset Writedown | -5.58 | -5 | -2 | -40 | -3 | -48 |
Pretax Income | -1,188 | -1,144 | -1,017 | -1,023 | -1,652 | -1,683 |
Income Tax Expense | 1.15 | 1 | 1 | 1 | 1 | 1 |
Net Income | -1,189 | -1,145 | -1,018 | -1,024 | -1,653 | -1,684 |
Net Income to Common | -1,189 | -1,145 | -1,018 | -1,024 | -1,653 | -1,684 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 52 | 50 | 40 | 36 | 31 | 28 |
Shares Outstanding (Diluted) | 52 | 50 | 40 | 36 | 31 | 28 |
Shares Change | 23.42% | 22.82% | 13.25% | 14.73% | 10.70% | 9.29% |
EPS (Basic) | -22.69 | -23.06 | -25.19 | -28.69 | -53.14 | -59.92 |
EPS (Diluted) | -22.69 | -23.06 | -25.19 | -28.69 | -53.14 | -59.92 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -1,120 | -1,028 | -954 | -1,731 | -1,509 |
Free Cash Flow Per Share | - | -22.56 | -25.43 | -26.73 | -55.64 | -53.70 |
Gross Margin | 100.00% | 66.67% | 100.00% | - | 100.00% | 100.00% |
Operating Margin | -16549.13% | -40233.33% | -52500.00% | - | -2749.23% | -2186.25% |
Profit Margin | -15852.13% | -38166.67% | -50900.00% | - | -2543.08% | -2105.00% |
Free Cash Flow Margin | - | -37333.33% | -51400.00% | - | -2663.08% | -1886.25% |
EBITDA | -1,236 | -1,204 | -1,049 | -1,106 | -1,787 | -1,734 |
D&A For EBITDA | 4.76 | 3 | 0.92 | 10 | 0.48 | 15 |
EBIT | -1,241 | -1,207 | -1,050 | -1,116 | -1,787 | -1,749 |